High materiality7/10
Vaxcyte (PCVX) PT Set at $120 at Cantor Fitzgerald - Pressure on Shares Explained by Challenging Market
Why it may matterVerify against the original reporting
buy
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Cantor Fitzgerald sets a $120 target for Vaxcyte; current price is $71.38, indicating meaningful upside.
- Cantor Fitzgerald PT $120; price $71.38.
Key facts
- 01
Target: $120
- 02
Posted price: $71.38
- 03
Analyst firm: Cantor Fitzgerald
- 04
Analyst: Carter Gould
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.